| |
|
|
|
|
|
|
|||
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 4834-4835.
The three musketeers of HSC developmentMAYO CLINIC
Hematopoietic stem cells (HSCs) are a key paradigm system for stem cell therapy applications. How these cells change from their multipotent to lineage-restricted cell states is still not fully understood. In this issue of Blood, McKinney-Freeman and colleagues show that members of a single transcription factor gene family are used in diverse and dynamic ways to implement this critical organogenesis program.
In the article by McKinley-Freeman and colleagues, these authors merge biological insight from diverse model systems. First, the caudal gene from the fruit fly (Drosophilia melanogaster) is identified as an important transcription factor in development. Second, in vivo data from the zebrafish demonstrate that several vertebrate orthologs of these genes are critical for blood development.1,2 Third, these authors deploy in vitro blood differentiation models based on embryonic stem cells that can be cultured to generate hematopoietic lineages. By the addition of 3 different orthologs of the caudal gene family from mammals, the authors show that these genes encode biochemically distinct protein forms that affect multiple aspects of HSC biology (see figure). Early in the life of an HSC lineage, cdx1 and cdx4 genes are capable of inducing differentiation, while cdx2 inhibits differentiation. However, in the hematopoietic progenitor differentiation step, cdx1 and cdx2 inhibit while cdx4 can enhance. This is critical, suggesting that the regulation of these genes provides a potential mechanism in HSC developmental decision-making processes. These genes do not appear to be the actual trigger, but they do appear to be important in implementing this key process in stem cell biology for blood lineages.
What are the broader implications of this work? First, assuming the in vitro system recapitulates the in vivo scenario, it implies that a similar focus on key transcription factor families is likely to yield important insight into other stem cell pathways. Secondly, this work suggests that these important differences among bioinformatically indistinguishable members of a protein family will need to be deduced using functional assay systems. The use of an in vitro stem cell–based model is one such tool, demonstrating a second and important role for in vitro culture systems for other organs. Will this be a common mechanism for other stem cell systems? That is not yet clear. But the HSC system is providing an important reference paradigm against which other systems can be compared.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests.
REFERENCES
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||